By expenditures
| Name | Title | Type |
|---|---|---|
| Cary Erskine | Business Office Manager | Auditee |
| Blake Stapp | Shareholder/Partner | Auditee |
| Cotii Huggins | EXECUTIVE DIRECTOR | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 402609 | 2024 | 2026-05-29 | 742243906 | $1.39M |
| 345422 | 2023 | 2025-03-10 | Ludwick Montgomery & Stapp PC | $1.30M |
| 2879 | 2022 | 2023-11-10 | Ludwick Montgomery & Stapp PC | $1.15M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 402609 | 2024 | 2026-05-29 | 1216138 | 2024-005 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216137 | 2024-005 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216136 | 2024-005 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216135 | 2024-004 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216134 | 2024-004 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216133 | 2024-004 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216132 | 2024-003 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216131 | 2024-003 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216130 | 2024-003 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216129 | 2024-002 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216128 | 2024-002 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216127 | 2024-002 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216126 | 2024-001 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216125 | 2024-001 | Material Weakness | Yes | B |
| 402609 | 2024 | 2026-05-29 | 1216124 | 2024-001 | Material Weakness | Yes | B |
| 345422 | 2023 | 2025-03-10 | 1102947 | 2023-002 | Significant Deficiency | - | B |
| 345422 | 2023 | 2025-03-10 | 1102946 | 2023-002 | Significant Deficiency | - | B |
| 345422 | 2023 | 2025-03-10 | 1102945 | 2023-002 | Significant Deficiency | - | B |
| 345422 | 2023 | 2025-03-10 | 1102944 | 2023-001 | Significant Deficiency | Yes | B |
| 345422 | 2023 | 2025-03-10 | 1102943 | 2023-001 | Significant Deficiency | Yes | B |
| 345422 | 2023 | 2025-03-10 | 1102942 | 2023-001 | Significant Deficiency | Yes | B |
| 345422 | 2023 | 2025-03-10 | 526505 | 2023-002 | Significant Deficiency | - | B |
| 345422 | 2023 | 2025-03-10 | 526504 | 2023-002 | Significant Deficiency | - | B |
| 345422 | 2023 | 2025-03-10 | 526503 | 2023-002 | Significant Deficiency | - | B |
| 345422 | 2023 | 2025-03-10 | 526502 | 2023-001 | Significant Deficiency | Yes | B |
| 345422 | 2023 | 2025-03-10 | 526501 | 2023-001 | Significant Deficiency | Yes | B |
| 345422 | 2023 | 2025-03-10 | 526500 | 2023-001 | Significant Deficiency | Yes | B |
| 2879 | 2022 | 2023-11-10 | 578102 | 2022-001 | Significant Deficiency | - | B |
| 2879 | 2022 | 2023-11-10 | 578101 | 2022-001 | Significant Deficiency | - | B |
| 2879 | 2022 | 2023-11-10 | 578100 | 2022-001 | Significant Deficiency | - | B |
| 2879 | 2022 | 2023-11-10 | 1660 | 2022-001 | Significant Deficiency | - | B |
| 2879 | 2022 | 2023-11-10 | 1659 | 2022-001 | Significant Deficiency | - | B |
| 2879 | 2022 | 2023-11-10 | 1658 | 2022-001 | Significant Deficiency | - | B |